Piperlotine ACAS# 389572-70-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 389572-70-7 | SDF | Download SDF |
PubChem ID | 773630 | Appearance | Powder |
Formula | C14H17NO2 | M.Wt | 231.3 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (E)-3-(4-methoxyphenyl)-1-pyrrolidin-1-ylprop-2-en-1-one | ||
SMILES | COC1=CC=C(C=C1)C=CC(=O)N2CCCC2 | ||
Standard InChIKey | JYEDISZKFNNREA-RMKNXTFCSA-N | ||
Standard InChI | InChI=1S/C14H17NO2/c1-17-13-7-4-12(5-8-13)6-9-14(16)15-10-2-3-11-15/h4-9H,2-3,10-11H2,1H3/b9-6+ | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Piperlotine A shows potent antiplatelet aggregation activity. |
Targets | PAFR |
Piperlotine A Dilution Calculator
Piperlotine A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.3234 mL | 21.6169 mL | 43.2339 mL | 86.4678 mL | 108.0847 mL |
5 mM | 0.8647 mL | 4.3234 mL | 8.6468 mL | 17.2936 mL | 21.6169 mL |
10 mM | 0.4323 mL | 2.1617 mL | 4.3234 mL | 8.6468 mL | 10.8085 mL |
50 mM | 0.0865 mL | 0.4323 mL | 0.8647 mL | 1.7294 mL | 2.1617 mL |
100 mM | 0.0432 mL | 0.2162 mL | 0.4323 mL | 0.8647 mL | 1.0808 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Icariside D2
Catalog No.:BCN7217
CAS No.:38954-02-8
- Isovitexin
Catalog No.:BCN5441
CAS No.:38953-85-4
- Vitexin 4'-glucoside
Catalog No.:BCC9252
CAS No.:38950-94-6
- Chelerythrine chloride
Catalog No.:BCN8322
CAS No.:3895-92-9
- SBHA
Catalog No.:BCC2425
CAS No.:38937-66-5
- Isodeoxyelephantopin
Catalog No.:BCN4638
CAS No.:38927-54-7
- erythro-Guaiacylglycerol
Catalog No.:BCN5440
CAS No.:38916-91-5
- Halaminol C
Catalog No.:BCN1787
CAS No.:389125-68-2
- Halaminol B
Catalog No.:BCN1748
CAS No.:389125-59-1
- Halaminol A
Catalog No.:BCN1788
CAS No.:389125-56-8
- Z-Glu(OtBu)-OH
Catalog No.:BCC2776
CAS No.:3886-08-6
- CK 869
Catalog No.:BCC6347
CAS No.:388592-44-7
- Prasugrel hydrochloride
Catalog No.:BCC4291
CAS No.:389574-19-0
- Prasugrel Maleic acid
Catalog No.:BCC4292
CAS No.:389574-20-3
- Raspberry ketone glucoside
Catalog No.:BCC8244
CAS No.:38963-94-9
- N-Acetylnorloline
Catalog No.:BCN2005
CAS No.:38964-35-1
- Eriodictyol-7-O-glucoside
Catalog No.:BCN4743
CAS No.:38965-51-4
- 2'-O-Methylperlatolic acid
Catalog No.:BCN5442
CAS No.:38968-07-9
- Ophiopogonin B
Catalog No.:BCN5378
CAS No.:38971-41-4
- α-Tocopherol phosphate
Catalog No.:BCC5420
CAS No.:38976-17-9
- (S)-CPW 399
Catalog No.:BCC7106
CAS No.:389888-02-2
- Gelsevirine
Catalog No.:BCN5443
CAS No.:38990-03-3
- 2-Acetyl-6-methoxynaphthalene
Catalog No.:BCC8514
CAS No.:3900-45-6
- Albiflorin
Catalog No.:BCN1264
CAS No.:39011-90-0
Isolation and identification of antiplatelet aggregatory principles from the leaves of Piper lolot.[Pubmed:17941696]
J Agric Food Chem. 2007 Nov 14;55(23):9436-42.
The methanolic extract of Piper lolot, having shown potent inhibitory activity on platelet aggregation induced by arachidonic acid (AA) and platelet activating factor (PAF), was subjected to activity-guided isolation to yield twelve new amide alkaloids, Piperlotine A-L (1-12), along with twenty-nine known compounds. Their structures were elucidated on the basis of spectroscopic analysis. The isolated compounds were tested for their inhibitory activity on the rabbit platelet aggregation. The compounds Piperlotine A (1), piperlotine C (3), piperlotine D (4), piperlotine E (5), 3-phenyl-1-(2,4,6-trihydroxyphenyl)propan-1-one (21), 3-(4-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one (22), 1-trans-cinnamoylpyrrolidine (24), sarmentine (26), pellitorine (27), methyl 3-phenylpropionate (32), and (10S)-10-hydroxypheophorbide a methyl ester (40) showed potent antiplatelet aggregation activity.